KPV Complete Research Guide 2026

KPV (lysine-proline-valine) is a tripeptide corresponding to the C-terminal amino acids 11-13 of alpha-melanocyte stimulating hormone (α-MSH). This small fragment retains the anti-inflammatory activity of the full α-MSH molecule while lacking the pigmentary effects mediated by the N-terminal regions — making it a focused research tool for studying anti-inflammatory pathways without the confounding melanocortin receptor pigmentation effects of the parent hormone.

Relationship to Alpha-MSH

Alpha-MSH is a 13-amino acid peptide with diverse biological activities including pigmentation (through MC1R), appetite regulation (through MC4R), and potent anti-inflammatory effects. Research seeking to isolate the anti-inflammatory activity from the other effects identified that the C-terminal tripeptide KPV retains substantial anti-inflammatory potency. This makes KPV a valuable research tool — it allows investigation of α-MSH's anti-inflammatory mechanisms without the systemic melanocortin effects that complicate research with the full peptide.

NF-κB Pathway Inhibition

The primary anti-inflammatory mechanism of KPV involves direct interference with NF-κB signaling — the master transcriptional regulator of inflammatory gene expression. Published research documented that KPV enters cells and reduces NF-κB nuclear translocation, thereby decreasing the transcription of pro-inflammatory cytokines including TNF-α, IL-1β, IL-6, and IL-8. This mechanism operates downstream of the inflammatory trigger, making KPV effective across diverse inflammatory contexts regardless of the initiating stimulus.

Notably, research documented that KPV can exert anti-inflammatory effects through both receptor-dependent (melanocortin receptor) and receptor-independent (direct intracellular) mechanisms. The receptor-independent intracellular activity is particularly significant as it enables KPV to act on cell types that do not express melanocortin receptors.

Gastrointestinal Research

One of the most studied applications of KPV involves inflammatory bowel disease research models. Published studies documented that KPV reduces intestinal inflammation in colitis models through NF-κB inhibition in intestinal epithelial cells and immune cells. A significant finding involved the PepT1 transporter — KPV is taken up by intestinal epithelial cells via the PepT1 di/tripeptide transporter, enabling targeted delivery to inflamed intestinal tissue where PepT1 expression is elevated during inflammation. This transporter-mediated uptake makes KPV particularly relevant for gut-specific anti-inflammatory research.

Dermatological Research

KPV has been studied in skin inflammation models including dermatitis and wound healing contexts. The anti-inflammatory activity that reduces excessive inflammatory signaling — combined with the absence of pigmentation effects that complicate research with full α-MSH — makes KPV a useful tool for dermatological inflammation research. Studies documented reduced inflammatory markers and improved healing parameters in treated skin models.

Antimicrobial Properties

Beyond anti-inflammatory activity, α-MSH and its fragments including KPV have demonstrated antimicrobial properties in research models. Published studies documented activity against certain bacterial and fungal species, suggesting a dual anti-inflammatory and antimicrobial profile that may be relevant in research models where infection and inflammation coexist.

KPV — Available for Research COA-verified, USA-synthesized. For laboratory and research use only. View Catalog

Research Use Only. Research Use DisclaimerKPV is a research compound intended for laboratory use only. Not for human consumption. For research use only per Ares Research terms.